Copyright Reports & Markets. All rights reserved.

Global Gut-on-a-Chip Market Research Report 2021

Request for Sample of this report
Buy now

1 Gut-on-a-Chip Market Overview

  • 1.1 Product Overview and Scope of Gut-on-a-Chip
  • 1.2 Gut-on-a-Chip Segment by Type
    • 1.2.1 Global Gut-on-a-Chip Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Heart-on-chip
    • 1.2.3 Human-on-chip
    • 1.2.4 Intestine-on-chip
    • 1.2.5 Kidney-on-chip
    • 1.2.6 Liver-on-chip
    • 1.2.7 Lung-on-chip
  • 1.3 Gut-on-a-Chip Segment by Application
    • 1.3.1 Gut-on-a-Chip Sales Comparison by Application: (2021-2027)
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Hospitals and Clinics
    • 1.3.4 Academic and Government Research Institutes
    • 1.3.5 Biotechnology Companies
  • 1.4 Global Gut-on-a-Chip Market Size Estimates and Forecasts
    • 1.4.1 Global Gut-on-a-Chip Revenue 2016-2027
    • 1.4.2 Global Gut-on-a-Chip Sales 2016-2027
    • 1.4.3 Gut-on-a-Chip Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gut-on-a-Chip Market Competition by Manufacturers

  • 2.1 Global Gut-on-a-Chip Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Gut-on-a-Chip Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Gut-on-a-Chip Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Gut-on-a-Chip Manufacturing Sites, Area Served, Product Type
  • 2.5 Gut-on-a-Chip Market Competitive Situation and Trends
    • 2.5.1 Gut-on-a-Chip Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Gut-on-a-Chip Players Market Share by Revenue
    • 2.5.3 Global Gut-on-a-Chip Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gut-on-a-Chip Retrospective Market Scenario by Region

  • 3.1 Global Gut-on-a-Chip Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Gut-on-a-Chip Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Gut-on-a-Chip Market Facts & Figures by Country
    • 3.3.1 North America Gut-on-a-Chip Sales by Country
    • 3.3.2 North America Gut-on-a-Chip Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Gut-on-a-Chip Market Facts & Figures by Country
    • 3.4.1 Europe Gut-on-a-Chip Sales by Country
    • 3.4.2 Europe Gut-on-a-Chip Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gut-on-a-Chip Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gut-on-a-Chip Sales by Region
    • 3.5.2 Asia Pacific Gut-on-a-Chip Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Gut-on-a-Chip Market Facts & Figures by Country
    • 3.6.1 Latin America Gut-on-a-Chip Sales by Country
    • 3.6.2 Latin America Gut-on-a-Chip Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Gut-on-a-Chip Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gut-on-a-Chip Sales by Country
    • 3.7.2 Middle East and Africa Gut-on-a-Chip Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Gut-on-a-Chip Historic Market Analysis by Type

  • 4.1 Global Gut-on-a-Chip Sales Market Share by Type (2016-2021)
  • 4.2 Global Gut-on-a-Chip Revenue Market Share by Type (2016-2021)
  • 4.3 Global Gut-on-a-Chip Price by Type (2016-2021)

5 Global Gut-on-a-Chip Historic Market Analysis by Application

  • 5.1 Global Gut-on-a-Chip Sales Market Share by Application (2016-2021)
  • 5.2 Global Gut-on-a-Chip Revenue Market Share by Application (2016-2021)
  • 5.3 Global Gut-on-a-Chip Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Emulate, Inc.
    • 6.1.1 Emulate, Inc. Corporation Information
    • 6.1.2 Emulate, Inc. Description and Business Overview
    • 6.1.3 Emulate, Inc. Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Emulate, Inc. Product Portfolio
    • 6.1.5 Emulate, Inc. Recent Developments/Updates
  • 6.2 AxoSim Technologies LLC
    • 6.2.1 AxoSim Technologies LLC Corporation Information
    • 6.2.2 AxoSim Technologies LLC Description and Business Overview
    • 6.2.3 AxoSim Technologies LLC Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AxoSim Technologies LLC Product Portfolio
    • 6.2.5 AxoSim Technologies LLC Recent Developments/Updates
  • 6.3 CN Bio Innovations
    • 6.3.1 CN Bio Innovations Corporation Information
    • 6.3.2 CN Bio Innovations Description and Business Overview
    • 6.3.3 CN Bio Innovations Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 CN Bio Innovations Product Portfolio
    • 6.3.5 CN Bio Innovations Recent Developments/Updates
  • 6.4 Hurel Corporation
    • 6.4.1 Hurel Corporation Corporation Information
    • 6.4.2 Hurel Corporation Description and Business Overview
    • 6.4.3 Hurel Corporation Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hurel Corporation Product Portfolio
    • 6.4.5 Hurel Corporation Recent Developments/Updates
  • 6.5 Ascendance Biotechnology, Inc.
    • 6.5.1 Ascendance Biotechnology, Inc. Corporation Information
    • 6.5.2 Ascendance Biotechnology, Inc. Description and Business Overview
    • 6.5.3 Ascendance Biotechnology, Inc. Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Ascendance Biotechnology, Inc. Product Portfolio
    • 6.5.5 Ascendance Biotechnology, Inc. Recent Developments/Updates
  • 6.6 Insphero AG
    • 6.6.1 Insphero AG Corporation Information
    • 6.6.2 Insphero AG Description and Business Overview
    • 6.6.3 Insphero AG Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Insphero AG Product Portfolio
    • 6.6.5 Insphero AG Recent Developments/Updates
  • 6.7 Mimetas B.V.
    • 6.6.1 Mimetas B.V. Corporation Information
    • 6.6.2 Mimetas B.V. Description and Business Overview
    • 6.6.3 Mimetas B.V. Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mimetas B.V. Product Portfolio
    • 6.7.5 Mimetas B.V. Recent Developments/Updates
  • 6.8 Nortis Inc.
    • 6.8.1 Nortis Inc. Corporation Information
    • 6.8.2 Nortis Inc. Description and Business Overview
    • 6.8.3 Nortis Inc. Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Nortis Inc. Product Portfolio
    • 6.8.5 Nortis Inc. Recent Developments/Updates
  • 6.9 Organovo Holdings, Inc.
    • 6.9.1 Organovo Holdings, Inc. Corporation Information
    • 6.9.2 Organovo Holdings, Inc. Description and Business Overview
    • 6.9.3 Organovo Holdings, Inc. Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Organovo Holdings, Inc. Product Portfolio
    • 6.9.5 Organovo Holdings, Inc. Recent Developments/Updates
  • 6.10 Tara Biosystems
    • 6.10.1 Tara Biosystems Corporation Information
    • 6.10.2 Tara Biosystems Description and Business Overview
    • 6.10.3 Tara Biosystems Gut-on-a-Chip Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Tara Biosystems Product Portfolio
    • 6.10.5 Tara Biosystems Recent Developments/Updates

7 Gut-on-a-Chip Manufacturing Cost Analysis

  • 7.1 Gut-on-a-Chip Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gut-on-a-Chip
  • 7.4 Gut-on-a-Chip Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gut-on-a-Chip Distributors List
  • 8.3 Gut-on-a-Chip Customers

9 Gut-on-a-Chip Market Dynamics

  • 9.1 Gut-on-a-Chip Industry Trends
  • 9.2 Gut-on-a-Chip Growth Drivers
  • 9.3 Gut-on-a-Chip Market Challenges
  • 9.4 Gut-on-a-Chip Market Restraints

10 Global Market Forecast

  • 10.1 Gut-on-a-Chip Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gut-on-a-Chip by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Gut-on-a-Chip by Type (2022-2027)
  • 10.2 Gut-on-a-Chip Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gut-on-a-Chip by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Gut-on-a-Chip by Application (2022-2027)
  • 10.3 Gut-on-a-Chip Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gut-on-a-Chip by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Gut-on-a-Chip by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Heart-on-chip
    Human-on-chip
    Intestine-on-chip
    Kidney-on-chip
    Liver-on-chip
    Lung-on-chip

    Segment by Application
    Pharmaceutical Companies
    Hospitals and Clinics
    Academic and Government Research Institutes
    Biotechnology Companies

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Emulate, Inc.
    AxoSim Technologies LLC
    CN Bio Innovations
    Hurel Corporation
    Ascendance Biotechnology, Inc.
    Insphero AG
    Mimetas B.V.
    Nortis Inc.
    Organovo Holdings, Inc.
    Tara Biosystems

    Buy now